Sign in
Characterizing Real-World Functional Outcomes in Patients with Geographic Atrophy: An IRIS Registry Analysis
Durga Borkar, MD
Annual Meeting Talks
2022
Baseline Factors Associated With 1-Year Outcomes in Phase III Comparison of SB11 (Approved Ranibizumab Biosimilar) With Reference Ranibizumab in nAMD
Neil M. Bressler, MD
Imaging Pearls in AMD
Netan Choudhry, MD, FRCS(C) FASRS
Glenn J. Jaffe, MD
Member Podcasts
Category: AMD-Non-Neovascular